Brugada Syndrome Ppt and 50 free published articles

The Brugada syndrome is a genetic disease that is characterised by abnormal electrocardiogram (ECG) findings and an increased risk of sudden cardiac death.

Brugada syndrome
Rey Vivo, MD
Syncope.ppt

Brugada Syndrome
Jessie Stewart
Brugada_syndrome.ppt

Advanced EKG patterns
Advanced EKG patterns.ppt

Genetic and Congenital Disorders
Genetic and Congenital Disorders.ppt

Clinical consequences of misinterpretation
MK Strecker-McGraw, MD, FACEP
Clinical consequences of misinterpretation.ppt

Pediatric Dysrhythmias
Brad Rodrigue, M.D.
Pediatric Dysrhythmias.ppt

Some Interesting EKGs
Justin Fox, MD
Interesting EKGs .ppt

Hypertrophic Cardiomyopathy
Rami Khouzam, MD
Hypertrophic_Cardiomyopathy.ppt

Top Ten (or 11) EKG Killers
Micelle Haydel, MD
Top Ten EKG Killers.ppt


50 free published articles

1. Brugada electrocardiographic pattern induced by fever.
2. Development of brugada syndrome following photodynamic therapy in a patient with cholangiocarcinoma.
3. The Brugada syndrome mutation A39V does not affect surface expression of neuronal rat Cav1.2 channels.
4. The Relationship Between Gastric Myoelectric Activity and SCN5A Mutation Suggesting Sodium Channelopathy in Patients With Brugada Syndrome and Functional Dyspepsia - A Pilot Study.
5. [ST segment elevation typical for Brugada syndrome after intracoronary acetylocholine injection with retrosternal pain in history].
6. Risk Stratification of Asymptomatic Patients With Brugada Type or J-Wave Type ECG.
7. Characteristics of induced ventricular fibrillation cycle length in symptomatic brugada syndrome patients.
8. C-reactive protein levels in the brugada syndrome.
9. Right ventricular dysfunction in patients with Brugada-like electrocardiography: a two dimensional strain imaging study.
10. Clarifying the arrhythmogenic substrate for Brugada syndrome.
11. Brugada pattern masking anterior myocardial infarction.
12. General anesthesia for electroconvulsive therapy with Brugada electrocardiograph pattern.
13. Hyperkalemia Mimicking a Pattern of Brugada Syndrome.
14. Effects of quinidine on the action potential duration restitution property in the right ventricular outflow tract in patients with brugada syndrome.
15. Ventricular and supraventricular arrhythmias and heart failure in a patient with left ventricular noncompaction and Brugada syndrome.
16. A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.
17. Prolonged QRS duration in lead V2 and risk of life-threatening ventricular Arrhythmia in patients with Brugada syndrome.
18. [Concealed Brugada syndrome that became apparent incidentally during atrial fibrillation therapy].
19. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.
20. ECG marker of high-risk in asymptomatic patients with Brugada syndrome.
21. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.
22. Risk determinants in individuals with a spontaneous type 1 Brugada ECG.
23. Identification of six novel SCN5A mutations in Japanese patients with Brugada syndrome.
24. General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism.
25. Brugada syndrome coinciding with fever and pandemic (H1N1) influenza.
26. Sudden cause of cardiac death-be aware of me: a case report and short review on brugada syndrome.
27. Atypical Brugada ECG phenotype involving ST-segment elevation in lateral leads.
28. A Case of Isolated Left Ventricular Noncompaction with Basal ECG-Tracing Strongly Suggestive for Type-2 Brugada Syndrome.
29. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome.
30. Electrocardiographic findings compatible with Brugada syndrome in a patient with febrile respiratory infection.
31. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.
32. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
33. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).
34. Ionic mechanisms of cellular electrical and mechanical abnormalities in Brugada syndrome.
35. A review of the mechanisms of ventricular arrhythmia in brugada syndrome.
36. Brugada syndrome: Controversies in Risk stratification and Management.
37. Exercise-induced Brugada sign.
38. Genetic analysis of Brugada syndrome and congenital long-QT syndrome type 3 in the Chinese.
39. Brugada electrocardiographic phenocopy in a patient with chronic Chagasic cardiomyopathy.
40. Ischemia-induced prominent J waves in a patient with Brugada syndrome.
41. Brugada sign unmasking the location of an acute myocardial infarction.
42. Brugada-type electrocardiographic changes induced by long-term lithium use.
43. Ebstein's anomaly with Brugada-like electrocardiogram pattern: a critical view.
44. [A case of asymptomatic Brugada syndrome with type 1 ECG pattern and cardiac arrest: an evaluation of the prognostic value of electrophysiologic study].
45. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization.
46. Brugada-like electrocardiogram detected after reconstructive operation for oesophageal cancer.
47. The spectrum of SCN5A gene mutations in Spanish Brugada syndrome patients.
48. Abnormal atrial repolarization and depolarization contribute to the inducibility of atrial fibrillation in Brugada syndrome.
49. The Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome.
50. Commentary on the Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome.